NCT06744855

Brief Summary

The goal of this study is to evaluate change in symptoms using semiconductor embedded gloves for hand osteoarthritis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 20, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

October 21, 2025

Status Verified

October 1, 2025

Enrollment Period

12 months

First QC Date

November 5, 2024

Last Update Submit

October 16, 2025

Conditions

Keywords

Semiconductor embedded fabric gloves for Hand Osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Change in pain as measured by the Visual Analog Scale (VAS)

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. The minimum number is zero meaning no pain and maximum number is 10 meaning the most pain the patient has every felt in their entire life. Lower scores are ideal while higher scores are indicative of the patient in a lot of pain.

    Baseline and weekly for 9 months

Secondary Outcomes (4)

  • Change in patient hand function as determined by the Australian Canadian Osteoarthritis Hand Index (AUSCAN)

    Baseline, 3 months, 6 months, and 9 months

  • Change in patient hand function as determined by the Functional Index for Hand Osteoarthritis (FIHOA)

    Baseline, 3 months, 6 months, and 9 months

  • Change in patient grip strength

    Baseline, 3 months, 6 months, and 9 months

  • Radiographic changes as determined by hand x-rays.

    Baseline and 9 months

Study Arms (2)

Semiconductor circulation gloves

ACTIVE COMPARATOR

The gloves will have semiconductors embedded in the fabric.

Device: Non-invasive circulation gloves

Placebo circulation gloves

PLACEBO COMPARATOR

The gloves will look identical to the active circulation gloves, but will not have semiconductors embedded into the fabric

Device: Fabric gloves

Interventions

Non-invasive class I medical device, circulation gloves with semiconductors embedded in the fabric.

Semiconductor circulation gloves

These gloves will look and feel identical to the active circulation gloves, but will not have semiconductors embedded in the fabric.

Placebo circulation gloves

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade \>1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification
  • Patients age 40-75
  • Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
  • Patients who are willing and able to sign corresponding research subject consent form.

You may not qualify if:

  • Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
  • Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months
  • Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis
  • Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week
  • Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome
  • Patient has a history of peripheral neuropathy
  • Patient has chronic pain conditions unrelated to hand condition
  • Patient has auto-immune or auto-inflammatory diseases
  • Patient has used tobacco within the last 90 days
  • Patient is not within the ages of 40-75
  • Patient has an active infection (local or systemic)
  • Patient is unwilling or unable to sign the corresponding research subject consent form
  • Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Altoona Center for Clinical Research

Duncansville, Pennsylvania, 16635, United States

Location

Related Publications (1)

  • Marino K, Lee R, Lee P. Effect of Germanium-Embedded Knee Sleeve on Osteoarthritis of the Knee. Orthop J Sports Med. 2019 Oct 25;7(10):2325967119879124. doi: 10.1177/2325967119879124. eCollection 2019 Oct.

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2024

First Posted

December 20, 2024

Study Start

January 1, 2025

Primary Completion

December 31, 2025

Study Completion

January 1, 2026

Last Updated

October 21, 2025

Record last verified: 2025-10

Locations